Inflammatory Biomarkers as Prognostic and Predictive Factor in Patients with COVID-19 | ||||
| Egyptian Journal of Medical Microbiology | ||||
| Volume 34, Issue 3, July 2025, Page 401-406 PDF (461.34 K) | ||||
| Document Type: New and original researches in the field of Microbiology. | ||||
| DOI: 10.21608/ejmm.2025.373367.1551 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Wafaa F. Hamad  1; Radhia H. Fadel2
| ||||
| 1College of Health and Medical Techniques, Baghdad, Middle Technical University, Baghdad, Iraq | ||||
| 2Department of Medical Laboratory Techniques, College of Health and Medical Techniques/ Kufa, Al-Furat Al-Awsat Technical University, 31003 Al-Kufa, Iraq | ||||
| Abstract | ||||
| Background: COVID-19 severity is often linked to excessive inflammatory responses. Biomarkers such as C-reactive protein (CRP), IL-17, and IL-33 have potential roles in inflammation and disease progression. Identifying these biomarkers may help predict disease severity and guide clinical management. Objective: This study aimed to investigate the role of CRP, IL-17, and IL-33 as indicator factors for Covid-19 severity. Methodology: The study involved ninety-five Covid-19 patients divided into mild and severe, along with (50) healthy controls. Levels of CRP, IL-17 and IL-33 were measured by ELISA in patients and healthy controls. Results: The results of the study indicated highly significant relation between the Covid-19 groups and healthy controls regarding C-reactive protein levels, as well as Il-17 and IL-33. Conclusion: The biomarkers are highly associated with Covid-19. Increased levels of IL-17, IL-33 facilitates lung injury through production other pro-inflammatory cytokines and that explain the immunopathology of Covid-19 infection, so could be used as a predictive factor for intensity of disease in patients with COV1ID-19. | ||||
| Keywords | ||||
| Lung injury; Cytokine storm; IL-33 level | ||||
|
Statistics Article View: 118 PDF Download: 22 |
||||
